Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 28, 2020, to report its financial results for the third quarter ended September 30, 2020. The key information is contained within the accompanying press release (Exhibit 99.1). This filing serves to officially announce the company's performance during the period, providing investors with crucial data to assess the company's ongoing operational and financial health. Investors should refer to the press release for specific details on revenue, profitability, and any forward-looking statements or strategic updates. The 8-K itself is a procedural document that incorporates the press release by reference, making the financial and operational details publicly available and auditable. It's important to note that the information furnished in this 8-K is not considered 'filed' for the purposes of liability under Section 18 of the Exchange Act, but it is still a critical disclosure for understanding BSX's recent performance.
Key Highlights
- 1Boston Scientific announced its third quarter 2020 financial results on October 28, 2020, via an 8-K filing.
- 2The 8-K filing includes a press release (Exhibit 99.1) detailing the financial performance for the quarter ended September 30, 2020.
- 3Investors can find specific financial metrics, such as revenue and earnings, within the furnished press release.
- 4This filing is a standard procedure to officially disseminate quarterly financial results to the market.
- 5The information provided in the 8-K is furnished and not deemed 'filed' under Section 18 of the Exchange Act, which impacts liability provisions.
- 6The company also provided the cover page XBRL tags as required by SEC regulations.